Results
1 -
10 of
111Effectiveness of the glucagon test in estimating islet function for liraglutide treatment in a lean diabetic patient with impaired insulin response to glucose, Diabetology International Physicochemical characterization of dipeptidyl peptidase-4 inhibitor alogliptin in physical mixtures with excipients, Journal of Thermal Analysis and Calorimetry The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial, Clinical and Experimental Nephrology GLP-1R activation for the treatment of stroke: Updating and future perspectives, Reviews in Endocrine and Metabolic Disorders DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics, Heart Failure Reviews Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials, Advances in Therapy Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Combination with Metformin, Advances in Therapy DPP-4 Inhibitors and Lipids: Systematic Review and Meta-Analysis, Advances in Therapy Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors, Clinical Pharmacokinetics